2023. Radioligand Therapy Beyond Neuroendocrine Tumours: Dosimetry, Supply Chain and Access. Translational Medicine & Therapeutics Journal. 2, 2 (Aug. 2023), 64–73. DOI:https://doi.org/10.5281/zenodo.22649084.